Omeprazol Ratiopharm (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Ratiopharm, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to manage conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults and children. GNH USA supplies Omeprazol Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omeprazol Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazol Ratiopharm is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes healing of the oesophageal lining. - Peptic ulcer disease: supports ulcer healing by maintaining a less acidic gastric environment. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with this rare endocrine disorder. - Helicobacter pylori eradication regimens (as part of combination therapy): enhances eradication success by reducing gastric acidity. - Erosive esophagitis: promotes mucosal healing and symptom relief.

Omeprazol Ratiopharm may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache - Diarrhea - Nausea - Abdominal pain - Flatulence - Constipation

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Clostridioides difficile‑associated colitis - Low magnesium levels (hypomagnesemia) - Acute interstitial nephritis - Fracture risk with long‑term use - Vitamin B12 deficiency with prolonged therapy.

When using Omeprazol Ratiopharm, consider the following precautions: - Assess renal function: adjust use in severe renal impairment. - Review concomitant medications: potential for altered absorption of drugs that require acidic pH. - Monitor long‑term therapy: evaluate need for periodic assessment of bone health and vitamin B12 status. - Pregnancy and lactation: use only if clearly indicated. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazole can affect the pharmacokinetics of several medicines. Interaction severity may vary.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk. - Atazanavir and other protease inhibitors: markedly decreased absorption. - Methotrexate (high‑dose): increased serum levels, risk of toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of INR values. - Diazepam: increased plasma concentrations. - Digoxin: enhanced absorption leading to higher serum levels. - Iron supplements: reduced absorption, consider timing separation. - Ketoconazole: decreased bioavailability.